Aryeh I Herman

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Comparison of available treatments for tobacco addiction
    Aryeh I Herman
    Department of Psychiatry, VA Connecticut Healthcare System, Yale University, West Haven, CT 06516, USA
    Curr Psychiatry Rep 12:433-40. 2010
  2. pmc Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report
    Mehmet Sofuoglu
    School of Medicine, Department of Psychiatry, VA Connecticut Healthcare System, Yale University, 950 Campbell Ave, Bldg 36 116A4, West Haven, CT, USA
    Psychopharmacology (Berl) 224:413-20. 2012
  3. pmc Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers
    Aryeh I Herman
    School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, Yale University, 950 Campbell Ave, Bldg 36 116A4, West Haven, CT 06516, USA
    Psychopharmacology (Berl) 220:611-7. 2012
  4. pmc Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine
    Mehmet Sofuoglu
    Department of Psychiatry and VA Connecticut Healthcare System, Yale University School of Medicine, West Haven, CT 06516, USA
    Neuropsychopharmacology 37:1509-16. 2012
  5. pmc Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans
    Mehmet Sofuoglu
    Department of Psychiatry and VA Connecticut Healthcare System, Yale University School of Medicine, 950 Campbell Ave, Bldg 36 116A4, West Haven, CT 06516, USA
    Psychopharmacology (Berl) 207:153-62. 2009
  6. pmc Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region
    Huiping Zhang
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    J Hum Genet 55:278-84. 2010
  7. pmc Cognitive effects of nicotine: genetic moderators
    Aryeh I Herman
    Department of Psychiatry and VA Connecticut Healthcare System, School of Medicine, Yale University, West Haven, CT 06516, USA
    Addict Biol 15:250-65. 2010
  8. doi request reprint Pharmacogenetics of nicotine addiction: role of dopamine
    Aryeh I Herman
    Yale University, School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, VA Medical Center, 950 Campbell Avenue, West Haven, CT 06516, USA
    Pharmacogenomics 15:221-34. 2014
  9. pmc Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence
    Aryeh I Herman
    Department of Psychiatry, University of Connecticut School of Medicine, Farmington, Connecticut, USA
    Am J Med Genet B Neuropsychiatr Genet 141:499-503. 2006

Detail Information

Publications9

  1. pmc Comparison of available treatments for tobacco addiction
    Aryeh I Herman
    Department of Psychiatry, VA Connecticut Healthcare System, Yale University, West Haven, CT 06516, USA
    Curr Psychiatry Rep 12:433-40. 2010
    ..However, effective treatments for many subpopulations, including smokers with psychiatric comorbidities as well as adolescent, pregnant, or postpartum smokers, remain to be developed and represent an important challenge...
  2. pmc Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report
    Mehmet Sofuoglu
    School of Medicine, Department of Psychiatry, VA Connecticut Healthcare System, Yale University, 950 Campbell Ave, Bldg 36 116A4, West Haven, CT, USA
    Psychopharmacology (Berl) 224:413-20. 2012
    ..The goal of this study was to characterize GAL's actions on multiple outcomes, including withdrawal severity and cognitive performance, as well as subjective and physiological responses to nicotine administered intravenously...
  3. pmc Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers
    Aryeh I Herman
    School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, Yale University, 950 Campbell Ave, Bldg 36 116A4, West Haven, CT 06516, USA
    Psychopharmacology (Berl) 220:611-7. 2012
    ..The goal of this study was to determine pregabalin's effects on smoking behavior, nicotine withdrawal, craving for cigarettes, and cognitive performance...
  4. pmc Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine
    Mehmet Sofuoglu
    Department of Psychiatry and VA Connecticut Healthcare System, Yale University School of Medicine, West Haven, CT 06516, USA
    Neuropsychopharmacology 37:1509-16. 2012
    ..These findings warrant further investigation, especially in treatment-seeking smokers undergoing cessation treatment...
  5. pmc Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans
    Mehmet Sofuoglu
    Department of Psychiatry and VA Connecticut Healthcare System, Yale University School of Medicine, 950 Campbell Ave, Bldg 36 116A4, West Haven, CT 06516, USA
    Psychopharmacology (Berl) 207:153-62. 2009
    ..How varenicline affects the pharmacological effects of pure nicotine has not been examined in humans. The goal of this study was to characterize varenicline's actions on nicotine's dose-dependent effects in abstinent smokers...
  6. pmc Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region
    Huiping Zhang
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
    J Hum Genet 55:278-84. 2010
    ..These results suggest that the minor G-allele of SNP rs569356 may enhance transcription factor binding and increase OPRD1 expression...
  7. pmc Cognitive effects of nicotine: genetic moderators
    Aryeh I Herman
    Department of Psychiatry and VA Connecticut Healthcare System, School of Medicine, Yale University, West Haven, CT 06516, USA
    Addict Biol 15:250-65. 2010
    ..Future research will provide a clearer understanding of the mechanism underlying the cognitive-enhancing actions of nicotine...
  8. doi request reprint Pharmacogenetics of nicotine addiction: role of dopamine
    Aryeh I Herman
    Yale University, School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, VA Medical Center, 950 Campbell Avenue, West Haven, CT 06516, USA
    Pharmacogenomics 15:221-34. 2014
    ..Future work should be conducted addressing these limitations to more effectively utilize DA genetic information to unlock the potential of smoking cessation pharmacogenetics. ..
  9. pmc Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence
    Aryeh I Herman
    Department of Psychiatry, University of Connecticut School of Medicine, Farmington, Connecticut, USA
    Am J Med Genet B Neuropsychiatr Genet 141:499-503. 2006
    ..These findings fail to replicate the original report of an association between SNPs adjacent to an alternative CNR1 exon 3 transcription start site and polysubstance abuse...